Safety and Efficacy of Autologous Endothelial Progenitor Cell CD 133 for Therapeutic Angiogenesis (PROGENITOR)

This study has been completed.
Fundación Mutua Madrileña
Information provided by (Responsible Party):
Pilar Jimenez Quevedo, Hospital San Carlos, Madrid Identifier:
First received: June 5, 2008
Last updated: August 4, 2013
Last verified: May 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2012
  Primary Completion Date: May 2009 (Final data collection date for primary outcome measure)